Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
INDV
INDV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INDV News
Divisadero Exits Entire Position in Stride
4d ago
Fool
Divisadero Exits Entire Position in Stride
4d ago
NASDAQ.COM
Indivior Pharmaceuticals Reports Q4 2025 Earnings Highlights
Feb 27 2026
seekingalpha
Indivior Q4 Earnings Exceed Expectations
Feb 26 2026
seekingalpha
Kevin Mahn Advises Investors to Focus on Long-Term Growth Amid Market Volatility
Jan 21 2026
Benzinga
Healthcare Sector Outperforms S&P 500 with 12.52% Gain and 3.20 Health Score
Jan 14 2026
seekingalpha
Indivior Stock Performance Review: Short-Term Decline vs. Long-Term Gains
Jan 10 2026
Yahoo Finance
Stonepine Capital Reduces Indivior Stake by 250,000 Shares, Valuation Drops by $2.75 Million
Dec 28 2025
NASDAQ.COM
Stonepine Capital Reduces Indivior Stake by $2.75 Million
Dec 28 2025
Fool
Indivior PLC Added to S&P SmallCap 600 Index, Enhancing Market Presence
Dec 22 2025
PRnewswire
Indivior PLC Added to S&P SmallCap 600 Index, Enhancing Market Presence
Dec 22 2025
Newsfilter
Indivior Reports SUBLOCADE Trial Results, 300mg Dose Significantly Increases Abstinence Rates
Dec 17 2025
Newsfilter
Indivior Reports SUBLOCADE Clinical Trial Results, Significantly Reducing Opioid Use
Dec 17 2025
PRnewswire
S&P 500 Index Adjustments: Six New Additions Announced
Dec 05 2025
PRnewswire
S&P 500 Index Adjustments: Additions of CRH and Others
Dec 05 2025
Newsfilter
The Remitly Review: Insights from Divisadero's $95 Million Exit on the Digital Currency Landscape
Dec 03 2025
NASDAQ.COM
Show More News
